WAKIX Demonstrated Efficacy and Safety in Clinical Studies

WAKIX was evaluated in clinical studies that included patients with narcolepsy type 1 and narcolepsy type 2

Learn more about the clinical study results for WAKIX in both excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy, and view the WAKIX safety profile from clinical studies.